AU569097B2

AU569097B2 – Insulin derivatives
– Google Patents

AU569097B2 – Insulin derivatives
– Google Patents
Insulin derivatives

Info

Publication number
AU569097B2

AU569097B2
AU30922/84A
AU3092284A
AU569097B2
AU 569097 B2
AU569097 B2
AU 569097B2
AU 30922/84 A
AU30922/84 A
AU 30922/84A
AU 3092284 A
AU3092284 A
AU 3092284A
AU 569097 B2
AU569097 B2
AU 569097B2
Authority
AU
Australia
Prior art keywords
insulin derivatives
insulin
derivatives
Prior art date
1983-07-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Application number
AU30922/84A
Other versions

AU3092284A
(en

Inventor
Ulrich Grau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hoechst AG

Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1983-07-22
Filing date
1984-07-20
Publication date
1988-01-21

1984-07-20
Application filed by Hoechst AG
filed
Critical
Hoechst AG

1985-01-24
Publication of AU3092284A
publication
Critical
patent/AU3092284A/en

1988-01-21
Application granted
granted
Critical

1988-01-21
Publication of AU569097B2
publication
Critical
patent/AU569097B2/en

2004-07-20
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

C07K14/575—Hormones

C07K14/62—Insulins

C07K14/622—Insulins at least 1 amino acid in D-form

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P3/00—Drugs for disorders of the metabolism

A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P3/00—Drugs for disorders of the metabolism

A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

C07K14/575—Hormones

C07K14/62—Insulins

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K38/00—Medicinal preparations containing peptides

Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC

Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10S930/00—Peptide or protein sequence

Y10S930/01—Peptide or protein sequence

Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

AU30922/84A
1983-07-22
1984-07-20
Insulin derivatives

Ceased

AU569097B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

DE19833326472

DE3326472A1
(en)

1983-07-22
1983-07-22

NEW INSULIN DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AND PHARMACEUTICAL AGENTS FOR TREATING THE DIABETES MELLITUS

DE3326472

1983-07-22

Publications (2)

Publication Number
Publication Date

AU3092284A

AU3092284A
(en)

1985-01-24

AU569097B2
true

AU569097B2
(en)

1988-01-21

Family
ID=6204660
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU30922/84A
Ceased

AU569097B2
(en)

1983-07-22
1984-07-20
Insulin derivatives

Country Status (20)

Country
Link

US
(1)

US4701440A
(en)

EP
(1)

EP0132770B1
(en)

JP
(2)

JPS6042397A
(en)

AR
(1)

AR241864A1
(en)

AT
(1)

ATE29729T1
(en)

AU
(1)

AU569097B2
(en)

CA
(1)

CA1246548A
(en)

DE
(2)

DE3326472A1
(en)

DK
(2)

DK172211B1
(en)

ES
(2)

ES534487A0
(en)

FI
(1)

FI79854C
(en)

GR
(1)

GR81551B
(en)

HU
(1)

HUT37805A
(en)

IE
(1)

IE57709B1
(en)

IL
(1)

IL72469A
(en)

NO
(1)

NO167810C
(en)

NZ
(1)

NZ208959A
(en)

PH
(1)

PH23014A
(en)

PT
(1)

PT78940A
(en)

ZA
(1)

ZA845620B
(en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE3327928A1
(en)

*

1983-08-03
1985-02-21
Hoechst Ag, 6230 Frankfurt

METHOD FOR PRODUCING INSULIN DERIVATIVES

DE3333640A1
(en)

*

1983-09-17
1985-04-25
Hoechst Ag, 6230 Frankfurt

METHOD FOR THE PRODUCTION OF INSULIN DERIVATIVES, THE B-CHAIN C-TERMINAL EXTENDED, NEW BASICALLY MODIFIED INSULIN DERIVATIVES, THE MEANS CONTAINING THEM AND THEIR USE

DE3501641A1
(en)

*

1985-01-19
1986-07-24
Hoechst Ag, 6230 Frankfurt

METHOD FOR OBTAINING INSULIN PRECURSORS FROM REACTION MIXTURES WHICH ARE INCLUDED IN THE FOLDING OF INSULIN PRECURSORS FROM THE CORRESPONDING S-SULPHONATES

US4946828A
(en)

*

1985-03-12
1990-08-07
Novo Nordisk A/S
Novel insulin peptides

DK113585D0
(en)

*

1985-03-12
1985-03-12
Novo Industri As

NEW PEPTIDES

US4764592A
(en)

*

1987-04-23
1988-08-16
Eli Lilly And Company
Crystalline human proinsulin and process for its production

DE3717370A1
(en)

*

1987-05-22
1988-12-01
Hoechst Ag

MIXED CRYSTALS FROM INSULIN AND INSULINE DERIVATIVES, METHOD FOR THE PRODUCTION OF THESE MIXED CRYSTALS, PHARMACEUTICAL AGENTS CONTAINING THESE MIXED CRYSTALS AND THEIR USE FOR TREATING DIABETES MELLITUS

US4789660A
(en)

*

1987-09-10
1988-12-06
American Home Products Corporation
Insulin administration using methyl and propyl paraben

DE3827533A1
(en)

*

1988-08-13
1990-02-15
Hoechst Ag

PHARMACEUTICAL PREPARATION FOR TREATING THE DIABETES MELLITUS

DE3837825A1
(en)

*

1988-11-08
1990-05-10
Hoechst Ag

NEW INSULIN DERIVATIVES, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THEM

HUT56857A
(en)

*

1988-12-23
1991-10-28
Novo Nordisk As
Human insulin analogues

US5716927A
(en)

*

1988-12-23
1998-02-10
Novo Nordisk A/S
Insulin analogs having a modified B-chain

DK134189D0
(en)

*

1989-03-20
1989-03-20
Nordisk Gentofte

INSULIN COMPOUNDS

DE3936876A1
(en)

*

1989-11-06
1991-05-23
Hoechst Ag

NEW INSULINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THE SAME

WO1992010284A2
(en)

1990-12-07
1992-06-25
Cnc Development, Inc.
Catalytic chemical reactor

YU66892A
(en)

*

1991-08-20
1995-10-24
Hoechst Ag.

PHOSPHOINOSYTOLGLICAN – A PEPTID WITH ACTION AS INSULIN

ZA928916B
(en)

*

1991-11-26
1994-05-18
Lilly Co Eli
Tri-arginine insulins

DE59209745D1
(en)

*

1991-11-29
1999-10-21
Hoechst Ag

Peptides with an insulin-like effect

US5504188A
(en)

*

1994-06-16
1996-04-02
Eli Lilly And Company
Preparation of stable zinc insulin analog crystals

DE59711533D1
(en)

1996-07-26
2004-05-27
Aventis Pharma Gmbh

Insulin derivatives with increased zinc binding

DE19649350A1
(en)

*

1996-11-28
1998-06-04
Hoechst Ag

Inositol glycans with an insulin-like effect

US6444641B1
(en)

1997-10-24
2002-09-03
Eli Lilly Company
Fatty acid-acylated insulin analogs

DE19825447A1
(en)

1998-06-06
1999-12-09
Hoechst Marion Roussel De Gmbh

New insulin analogues with increased zinc formation

WO2000075365A2
(en)

1999-06-08
2000-12-14
University Of Iowa Research Foundation
Compounds and methods to enhance raav transduction

US6852694B2
(en)

2001-02-21
2005-02-08
Medtronic Minimed, Inc.
Stabilized insulin formulations

WO2002066385A1
(en)

*

2001-02-21
2002-08-29
Seiwa Pro Co., Ltd.
Remover for scale deposited on titanium material

DE10114178A1
(en)

2001-03-23
2002-10-10
Aventis Pharma Gmbh

Zinc-free and low-zinc insulin preparations with improved stability

DE10227232A1
(en)

*

2002-06-18
2004-01-15
Aventis Pharma Deutschland Gmbh

Sour insulin preparations with improved stability

WO2004090145A2
(en)

2003-03-31
2004-10-21
University Of Iowa Research Foundation
Compounds and methods to enhance raav transduction

WO2004104026A1
(en)

*

2003-05-21
2004-12-02
Biotech Tools S.A.
Peptide complex

US7833513B2
(en)

2004-12-03
2010-11-16
Rhode Island Hospital
Treatment of Alzheimer’s Disease

CR20170369A
(en)

2008-10-17
2017-11-01
Sanofi Aventis Deutschland

COMBINATION OF AN INSULIN AND A GLP-1 AGONIST (Divisional 2011-0188)

JP5973918B2
(en)

2009-11-13
2016-08-23
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング

Pharmaceutical composition comprising a GLP-1 agonist and methionine

CN102711805A
(en)

2009-11-13
2012-10-03
赛诺菲-安万特德国有限公司
Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine

CA2809321C
(en)

2010-08-30
2018-08-14
Sanofi-Aventis Deutschland Gmbh
Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2

US9821032B2
(en)

2011-05-13
2017-11-21
Sanofi-Aventis Deutschland Gmbh
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin

ES2550357T3
(en)

2011-08-29
2015-11-06
Sanofi-Aventis Deutschland Gmbh

Pharmaceutical combination for use in glycemic control in type 2 diabetes patients

TWI559929B
(en)

2011-09-01
2016-12-01
Sanofi Aventis Deutschland
Pharmaceutical composition for use in the treatment of a neurodegenerative disease

FI3229828T3
(en)

2014-12-12
2023-05-29
Sanofi Aventis Deutschland
Insulin glargine/lixisenatide fixed ratio formulation

TWI748945B
(en)

2015-03-13
2021-12-11
德商賽諾菲阿凡提斯德意志有限公司
Treatment type 2 diabetes mellitus patients

TW201705975A
(en)

2015-03-18
2017-02-16
賽諾菲阿凡提斯德意志有限公司
Treatment of type 2 diabetes mellitus patients

WO2017139381A1
(en)

2016-02-08
2017-08-17
University Of Iowa Research Foundation
Methods to produce chimeric adeno-associated virus/bocavirus parvovirus

AU2017229347A1
(en)

2016-03-07
2018-11-01
University Of Iowa Research Foundation
AAV-mediated expression using a synthetic promoter and enhancer

CN113164764A
(en)

2018-09-19
2021-07-23
兹洛有限公司
Glucose-sensitive insulin and use thereof

Citations (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU3146084A
(en)

*

1983-08-03
1985-02-07

Hoechst A.G.

Preparation of insulin derivatives

AU3307284A
(en)

*

1983-09-17
1985-03-21

Hoechst Aktiengesellschaft

Preparation of insulm derivatives, the b chain of which is lengthened c-terminally

AU3341984A
(en)

*

1983-09-23
1985-03-28

Hoechst A.G.

Insulin derivatives modified in the b30 position

Family Cites Families (7)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE2256215C3
(en)

*

1972-11-16
1981-01-08
Hoechst Ag, 6000 Frankfurt

Insulin preparation containing crystalline insulin and amorphous desphenylalanine8 ‘-insulin

DE2460753A1
(en)

*

1974-12-21
1976-06-24
Hoechst Ag

METHOD FOR MANUFACTURING HUMAN INSULIN

DK146482C
(en)

*

1979-04-13
1986-10-06
Shionogi & Co

METHOD FOR PREPARING A B30-THREONINE INSULIN

DK319780A
(en)

*

1980-07-24
1982-01-25
Forenede Bryggerier As

PROCEDURE FOR ENZYMATIC REPLACEMENT OF B-30 AMINO ACID IN INSULINES

DE3209184A1
(en)

*

1982-03-13
1983-09-15
Hoechst Ag, 6230 Frankfurt

METHOD FOR CONVERTING PRAEPROINSULIN ANALOGS TO INSULINES

NL8201650A
(en)

*

1982-04-21
1983-11-16
Akzo Nv

SEMISYNTHETIC PREPARATION OF HUMANE INSULIN.

JPH118546A
(en)

*

1997-04-24
1999-01-12
Hitachi Ltd
Cmos circuit

1983

1983-07-22
DE
DE19833326472
patent/DE3326472A1/en
not_active
Withdrawn

1984

1984-07-16
HU
HU842766A
patent/HUT37805A/en
unknown

1984-07-17
AR
AR84297267A
patent/AR241864A1/en
active

1984-07-18
DE
DE8484108442T
patent/DE3466227D1/en
not_active
Expired

1984-07-18
AT
AT84108442T
patent/ATE29729T1/en
not_active
IP Right Cessation

1984-07-18
EP
EP84108442A
patent/EP0132770B1/en
not_active
Expired

1984-07-18
GR
GR75343A
patent/GR81551B/el
unknown

1984-07-19
PT
PT78940A
patent/PT78940A/en
not_active
IP Right Cessation

1984-07-19
FI
FI842914A
patent/FI79854C/en
not_active
IP Right Cessation

1984-07-20
AU
AU30922/84A
patent/AU569097B2/en
not_active
Ceased

1984-07-20
NO
NO842977A
patent/NO167810C/en
not_active
IP Right Cessation

1984-07-20
NZ
NZ208959A
patent/NZ208959A/en
unknown

1984-07-20
DK
DK358284A
patent/DK172211B1/en
not_active
IP Right Cessation

1984-07-20
JP
JP59149784A
patent/JPS6042397A/en
active
Granted

1984-07-20
ES
ES534487A
patent/ES534487A0/en
active
Granted

1984-07-20
IE
IE1889/84A
patent/IE57709B1/en
not_active
IP Right Cessation

1984-07-20
ZA
ZA845620A
patent/ZA845620B/en
unknown

1984-07-20
CA
CA000459386A
patent/CA1246548A/en
not_active
Expired

1984-07-20
PH
PH31009A
patent/PH23014A/en
unknown

1984-07-20
IL
IL72469A
patent/IL72469A/en
not_active
IP Right Cessation

1984-09-06
ES
ES535706A
patent/ES8505646A1/en
not_active
Expired

1986

1986-06-06
US
US06/873,456
patent/US4701440A/en
not_active
Expired – Lifetime

1989

1989-02-22
JP
JP1040427A
patent/JPH01294634A/en
active
Granted

1990

1990-01-04
DK
DK001790A
patent/DK172209B1/en
not_active
IP Right Cessation

Patent Citations (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU3146084A
(en)

*

1983-08-03
1985-02-07
Hoechst A.G.
Preparation of insulin derivatives

AU3307284A
(en)

*

1983-09-17
1985-03-21
Hoechst Aktiengesellschaft
Preparation of insulm derivatives, the b chain of which is lengthened c-terminally

AU3341984A
(en)

*

1983-09-23
1985-03-28
Hoechst A.G.
Insulin derivatives modified in the b30 position

Also Published As

Publication number
Publication date

DK1790A
(en)

1990-01-04

IE57709B1
(en)

1993-03-10

NO842977L
(en)

1985-01-23

JPH01294634A
(en)

1989-11-28

PH23014A
(en)

1989-03-03

GR81551B
(en)

1984-12-11

JPH052654B2
(en)

1993-01-13

FI842914A0
(en)

1984-07-19

FI79854B
(en)

1989-11-30

ATE29729T1
(en)

1987-10-15

HUT37805A
(en)

1986-02-28

NO167810B
(en)

1991-09-02

DK358284A
(en)

1985-01-23

FI842914A
(en)

1985-01-23

ES8504678A1
(en)

1985-04-16

DE3326472A1
(en)

1985-02-14

EP0132770B1
(en)

1987-09-16

DK1790D0
(en)

1990-01-04

ES535706A0
(en)

1985-06-01

DK172211B1
(en)

1998-01-05

JPH0357119B2
(en)

1991-08-30

PT78940A
(en)

1984-08-01

NO167810C
(en)

1991-12-18

DK358284D0
(en)

1984-07-20

ES534487A0
(en)

1985-04-16

US4701440A
(en)

1987-10-20

DE3466227D1
(en)

1987-10-22

IL72469A
(en)

1989-07-31

ZA845620B
(en)

1985-02-27

DK172209B1
(en)

1998-01-05

ES8505646A1
(en)

1985-06-01

NZ208959A
(en)

1989-02-24

AR241864A1
(en)

1993-01-29

EP0132770A1
(en)

1985-02-13

FI79854C
(en)

1990-03-12

IE841889L
(en)

1985-01-22

JPS6042397A
(en)

1985-03-06

AU3092284A
(en)

1985-01-24

IL72469A0
(en)

1984-11-30

CA1246548A
(en)

1988-12-13

Similar Documents

Publication
Publication Date
Title

AU569097B2
(en)

1988-01-21

Insulin derivatives

AU2290088A
(en)

1989-01-05

Halogen-aniline derivatives

AU567140B2
(en)

1987-11-12

Sulphonamido-benzamide derivatives

AU571494B2
(en)

1988-04-21

1- phenyl-2-azole-ethylamino-carbonyl derivatives

AU2951884A
(en)

1985-06-13

Tetrahydropyridazinone derivatives

AU3320184A
(en)

1985-03-28

Pyridoinole derivatives

AU2983384A
(en)

1985-01-03

Spirosuccinimide derivatives

AU577333B2
(en)

1988-09-22

Acylamino-s-triazine derivatives

AU562795B2
(en)

1987-06-18

Pyrrolo-thiazole derivatives

AU570047B2
(en)

1988-03-03

3-phenyl-4-cyanopyrrole derivatives

AU574383B2
(en)

1988-07-07

Acylindole derivatives

AU565020B2
(en)

1987-09-03

1-benzazepine derivatives

AU563515B2
(en)

1987-07-09

3-indolecarboxamide derivatives

AU3022984A
(en)

1985-01-17

Formamidoxime derivatives

AU573268B2
(en)

1988-06-02

2-azacycloalkylthiopenem derivatives

AU3668384A
(en)

1985-06-20

Tetrazole-5-carboxamide derivatives

AU580972B2
(en)

1989-02-09

Phenylethanamine derivatives

AU2559584A
(en)

1984-09-20

2-cyano-imidazopyridine derivatives

AU558705B2
(en)

1987-02-05

Gonadoliberine derivatives

AU568527B2
(en)

1988-01-07

Carboxy-thiazolopyrimidine derivatives

AU582554B2
(en)

1989-04-06

Pyrimidoisoquinoline derivatives

AU567189B2
(en)

1987-11-12

Azolyl-tetrahydrofuran-2-ylidene-methane derivatives

AU2769084A
(en)

1984-11-15

Bispiperidine derivatives

AU566160B2
(en)

1987-10-08

Azolyl-tetrahydrofuran-2-ylidene-methane derivatives

AU3601784A
(en)

1985-06-06

5-phenyl-pyrazin-2-one derivatives

Legal Events

Date
Code
Title
Description

2003-02-20
MK14
Patent ceased section 143(a) (annual fees not paid) or expired

Download PDF in English

None